Dr. Feng Ren will dissect Insilico’s blueprint for "source innovation" in AI drug discovery. (IMAGE)

InSilico Medicine

Dr. Feng Ren will dissect Insilico’s blueprint for "source innovation" in AI drug discovery.

Caption

This journey spans from industry-leading intelligent target identification and disruptive de novo molecular generation to the cutting-edge integration of AI Agent technologies across the entire R&D pipeline. He will demonstrate how Insilico Medicine uses technology as a catalyst to continuously push and redefine the ultimate boundaries of AI-driven drug discovery.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.